Clarification of AXA shareholding in AstraZeneca

RNS Number : 5953J

AstraZeneca PLC

13 June 2014

Clarification statement regarding AXA's holdings in AstraZeneca PLC

AstraZeneca PLC (the 'Company') notes that a number of media sources have reported an aggregate interest held by AXA S.A. and its subsidiary undertakings (the 'AXA Group') in the ordinary share capital of the Company, based on out of date information.

Consequently, the Company wishes to clarify the current holdings of AXA S.A. and its subsidiary undertakings in the ordinary share capital of the Company.

Based on the issued share capital of the Company with voting rights of 1,262,502,850 ordinary shares of US$0.25 announced on 2 June 2014, the disaggregated interests of the AXA Group are as set out below. Accordingly, as at 11 June 2014, neither AXA S.A. itself nor any of its subsidiary undertakings held a notifiable interest under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

	Number of shares with voting rights	Percentage of voting rights
AXA Investment Managers S.A.	11,685,089	0.93%
AXA S.A.	759,758	0.06%
AllianceBernstein	989,364	0.08%